Kamran Alam
Director of Finance/CFO chez TAYSHA GENE THERAPIES, INC.
Fortune : 445 659 $ au 31/03/2024
Provenance du réseau au premier degré de Kamran Alam
Entité | Type d'entité | Industrie | |
---|---|---|---|
28
| Extinct | Biotechnology | 28 |
Public Company | Biotechnology | 21 | |
9
| Public Company | Pharmaceuticals: Major | 9 |
Public Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kamran Alam via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
BAXTER INTERNATIONAL INC. | Medical Specialties | President Chief Tech/Sci/R&D Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Director/Board Member | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | General Counsel Corporate Officer/Principal | |
INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
HOSPIRA, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Notre Dame | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member Founder Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Adams Street Partners LLC
Adams Street Partners LLC Investment ManagersFinance Adams Street Partners LLC (Adams Street Partners) is a private equity firm founded in 1972 by George H Spencer and Shahab Rashid. The firm is headquartered in Chicago, IL, with offices in Austin, Beijing, Boston, London, Menlo Park, Munich, New York, Seoul, Singapore, Sydney and Tokyo. | Investment Managers | Director/Board Member Private Equity Investor | |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Illinois | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
PBM Products LLC
PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens. | Food: Meat/Fish/Dairy | Chief Executive Officer Corporate Officer/Principal | |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
PBM Pharmaceuticals, Inc.
PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel Chief Tech/Sci/R&D Officer Human Resources Officer | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal President | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Chairman Director/Board Member | |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
ICOSAVAX, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SalioGen Therapeutics, Inc.
SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Director/Board Member | |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Illinois Biotechnology Innovation Organization | Director/Board Member Director/Board Member |
Statistiques
Internationale
Etats-Unis | 49 |
Irlande | 2 |
France | 2 |
Sectorielle
Health Technology | 32 |
Consumer Services | 12 |
Commercial Services | 5 |
Finance | 2 |
Consumer Non-Durables | 2 |
Opérationnelle
Director/Board Member | 257 |
Corporate Officer/Principal | 139 |
Independent Dir/Board Member | 82 |
Undergraduate Degree | 41 |
Chief Tech/Sci/R&D Officer | 39 |
Relations les plus connectées
Insiders | |
---|---|
Jonathan Leff | 45 |
Patrick Enright | 41 |
Norbert Riedel | 29 |
Sean Stalfort | 28 |
Paul Manning | 26 |
Carole Nüchterlein | 26 |
Terry Gould | 26 |
Daniel Welch | 24 |
Sean Nolan | 18 |
Bill Gantz | 18 |
Frank Verwiel | 16 |
Philip Donenberg | 15 |
Sukumar Nagendran | 15 |
Bong Koh | 14 |
Joao Siffert | 14 |
- Bourse
- Insiders
- Kamran Alam
- Connexions Sociétés